Arboretum Ventures
Venture capitalAnn Arbor · Pre-Seed–Series A · 31 people tracked
Also known as ARBORETUM VENTURES, LLC
Investment thesis
Arboretum Ventures pursues a strategy of investing in under-ventured geographies and sectors within healthcare, emphasizing deep relationships with entrepreneurs, executives, and investment partners across the industry. The firm targets early-stage healthcare startups that solve large healthcare problems and can deliver transformational impact, backing teams that are diverse in thought, geography, and demographics. It focuses on medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies, aiming to identify companies that create value in a capital-efficient manner, accelerate portfolio value, and generate superior returns while positively impacting patients and communities.
Source: firm website, verified Aug 3, 2026.
Team · 31 people
from the firm's website & public directories
What they invest in
from 29 of 47 portfolio companiesHealthtech ×23Medical Devices ×16Biotech ×10Digital Health ×7Deep Tech ×5Enterprise Software ×2Advanced Manufacturing ×1Data & Infrastructure ×1
HQs:United States×32
Investments · 47 tracked
founders shown can be your intro pathShoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis.
HardwareHealthtechMedical DevicesNorthern California, US
Robert Ball(CEO & Executive Chairman)Matthew Ahearn(Chief Operating Officer)Geoff Pardo(Director)Jeff Points(Executive Officer)Paul Buckman(Director)Mike Carusi(Director)
San Jose, US
Jeffrey W. Dunn(Executive Officer, Director)Mark Reiley(Director)Timothy E. Davis(Director)John G. Freund(Director)David Bonita(Director)Karen A. Licitra(Director)
PartnerTim Petersen· led
HealthtechSt Louis, US
David N. Schopp(Director)Andrea M. Clegg(Executive Officer)Louis Silverman(Executive Officer, Director)John Reardon(Director)Barbara Lubash(Director)Michael Mikolajczyk(Director)
Board seatTimothy B. Petersen· per SEC Form D · $7.3M raise · filed Jul 2015
Allay Therapeutics develops ultra-sustained analgesic products for post-surgical pain management.
BiotechHealthtechMedical DevicesSan Jose, US
Adam Gridley(Executive Officer, Director)Kristen Howells(Executive Officer)Josh Makower(Director)Hanson S. Gifford III(Director)Tak Cheung(Director)Karun D. Naga(Executive Officer, Director)
Board seatPaul McCreadie· per SEC Form D
ArborMetrix provides a software platform for healthcare quality improvement that aggregates and analyzes patient data to help providers, payers, and health systems optimize clinical and financial performance, reduce adverse events, and improve outcomes.
Data & InfrastructureEnterprise SoftwareHealthtechAnn Arbor, US
Brett Furst(Executive Officer, Director)Christian Birkmeyer(Executive Officer)John Birkmeyer, M.D.(Director)Anthony Grover(Director)Mark McClellan(Director)Steven Richvalsky(Executive Officer)
Board seatTimothy Petersen· per SEC Form D
HealthtechChagrin Falls, US
Jennifer Coleman(Director)Michael Ross(Director)Kevin Bramer(Executive Officer, Director)Ryan Caruso(Executive Officer)Timothy Petersen(Director)Koleman Karleski(Director)
Board seatTom Shehab· per SEC Form D · $2.5M raise · filed Jan 2016
HealthtechIrvine, US
Timothy Petersen(Director)Barbara Lubash(Director)Edward Wristen(Director)Toby Thomas(Executive Officer)John Huntz(Director)Alec Cunningham(Executive Officer, Director)
Board seatTimothy Petersen· per SEC Form D · $15.6M raise · filed Jul 2015
Convergent Dental manufactures Solea, a CO2 laser system for dental procedures that operates at a novel 9.3-micron wavelength, enabling anesthesia-free and suture-free treatments across soft and hard tissues.
Enterprise SoftwareHealthtechMedical DevicesNatick, US
Leonard Hedge(Director)Michael J. Cataldo(Executive Officer, Director)Bart Doedens(Director)Warren Thaler(Director)William R. Cowen(Director)Nathan P. Monty(Executive Officer, Director)
Board seatTimothy PetersenTimothy B. Petersen· per SEC Form D
Francis Medical develops the Vanquish procedure, a medical device treatment for benign prostatic hyperplasia that uses radiofrequency energy to ablate prostate tissue.
Digital HealthHealthtechMedical DevicesMaple Grove, US
Michael Hoey(Director)Michael Kujak(Executive Officer, Director)
BoardAndrew Cleeland(Director)David Adair(Director)Andre de Bruin(Director)
Board seatJan Garfinkle· per SEC Form D
Westminster, US
BRIAN GILLETT(Executive Officer)ROBERT SEHRING(Director)ANGELA MCFARLAND(Executive Officer)SCOTT JOHNSON(Executive Officer, Director)LAURA MEDINA(Executive Officer)RIKARD STEIBER(Director)
Board seatThomas Shehab· per SEC Form D · $9.3M raise · filed Jun 2021
BiotechAlbuquerque, US
Thomas Duensing(Executive Officer)Dan Kidle(Director)Dennis Hynson(Executive Officer)Jack T. Ball(Director)J. Michael Schafer(Director)Janette Phi(Executive Officer)
Board seatTim PetersenDan Kidle· per SEC Form D · $6M raise · filed Jul 2015
Koya Medical develops medical devices for lymphedema, chronic venous insufficiency, and deep vein thrombosis treatment.
HealthtechMedical Devices<UNKNOWN>, US
Josh Baltzell(Director)Jan Garfinkle(Director)Anand Doraiswamy(Executive Officer, Director)
Board seatJan Garfinkle· per SEC Form D
Motif Neuro develops neural devices to monitor and regulate mental health and performance, with an initial focus on treatment-resistant depression using bioelectronic implants called DOT that are deployed via outpatient procedure.
BiotechDigital HealthHealthtechMedical DevicesHouston, US
Anthony Arnold(Director)Jacob Robinson(Executive Officer, Director)Thomas M. Shehab(Director)Amy Kruse(Director)
Board seatThomas M. Shehab· per SEC Form D
HealthtechAnn Arbor, US
Nicole Walker(Director)Jan Garfinkle(Director)Sundaresh Brahmasandra(Executive Officer)Edward Michael(Director)William Burkoth(Director)Jeffrey Williams(Executive Officer, Director)
Board seatJan GarfinkleNicole Walker· per SEC Form D · $20M raise · filed Apr 2016
Maple Grove, US
Michael Hoey(Executive Officer, Director)Patrick Fabian(Executive Officer)Andre de Bruin(Director)Tom Lowe(Director)Glen Nelson(Director)Maximillian Fiore(Executive Officer)
Board seatJan Garfinkle· per SEC Form D · $8M raise · filed Feb 2015
Pioneering the development of prescription digital therapeutics.
HealthtechBoston, US
Antoun Nabhan(Executive Officer)Corey McCann(Executive Officer, Director)Andrew Schwab(Director)Timothy Petersen(Director)Christopher Guiffre(Executive Officer)
BoardZack Lynch(Director)
Board seatTimothy PetersenTim Petersen· per SEC Form D · $51M raise · filed Jan 2018
Seattle, US
Robert Shepler(Director)Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)Brian Daniels(Director)Joseph Victor(Executive Officer, Director)Frank Witney(Director)
Board seatJan Garfinkle· per SEC Form D
Reprieve Cardiovascular develops therapies for heart failure patients, focusing on intelligent decongestion management to accelerate fluid removal.
HealthtechMedical DevicesMilford, US
Hanson S. Gifford III(Director)Tony Fields(Executive Officer)Adam Bartnik(Executive Officer)Mark Pacyna(Executive Officer, Director)Jim Dillon(Executive Officer, Director)Gregory W Mann(Executive Officer)
Board seatJan Garfinkle· per SEC Form D
SonarMD is a digital monitoring platform for patients with inflammatory bowel disease that uses validated questionnaires and proprietary algorithms to detect deteriorating gut health between clinical visits.
Digital HealthHealthtechMedical DevicesChicago, US
LAWRENCE R KOSINSKI(Director)BETH HOUCK(Executive Officer, Director)inJohn Starr(Executive Officer)Anna Haghgooie(Director)Devin Gross(Executive Officer, Director)
Board seatCharity TarnThomas M ShehabTom Shehab· per SEC Form D
Strata Oncology provides precision oncology services, focusing on genomic analysis and clinical research to establish new standards of care for cancer treatment.
BiotechDigital HealthMedical DevicesAnn Arbor, US
Daniel Rhodes(Executive Officer, Director)Matthew Martin(Executive Officer)Jeffrey Williams(Executive Officer, Director)Name not fully specified on page
BoardChristopher O'Donnell(Director)David Rubin(Director)
Board seatJan GarfinkleNicole Walker· per SEC Form D
HealthtechAnn Arbor, US
Jeffrey Williams(Director)Guy Jordan(Director)Tim Petersen(Director)Colleen Spencer(Executive Officer)Eric Sandberg(Executive Officer)Henry Brown(Director)
Board seatTim Petersen· per SEC Form D · $2M raise · filed Oct 2015
Dexter, US
Charles Moret(Director)Jennifer Baird(Executive Officer, Director)Jeff Basch(Executive Officer)
Board seatThomas Shehab· per SEC Form D · $11.5M raise · filed Mar 2019
BiotechLincoln, US
Tom Shehab(Director)Fred Robertson(Director)Tao Lin(Director)John P. Murphy(Executive Officer, Director)Fernando Pacheco(Director)Mukund Srinivasan(Executive Officer)
Board seatTom Shehab· per SEC Form D
Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products.
Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Jeffrey S. Williams(Director)Brandon McNaughton(Executive Officer, Director)James Militello(Executive Officer)Kalyan Handique(Executive Officer, Director)Douglas Neal(Director)John Younger(Executive Officer, Director)
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Jill Schiaparelli(Executive Officer, Director)Thomas Shehab, MD(Director)Kevin Wasserstein(Director)
BioIQ provides at-home healthcare screening and testing solutions delivered through a vertically integrated platform serving employers, health plans, providers, and government agencies.
Digital HealthHealthtechSanta Barbara, US
Kathleen Shanahan(Director)Brandon Cady(Director)Brent Peus(Executive Officer)Jeff Closs(Director)Patrick Cua(Director)Justin Bellante(Executive Officer, Director, Promoter)
PartnerPaul McCreadie· led
BrightSpec develops spectraMRR, a molecular rotational resonance spectroscopy platform for rapid identification and quantitation of molecules in complex mixtures.
BiotechDeep TechMedical DevicesWaltham, US
Rick Gordon(CEO)inTimothy Germann(Director)David Cash(Director)inWalter Colsman(Executive Officer, Director)JAFFRAY WOODRIFF(Director)ROBERT LLOYD(Executive Officer, Director)
Enumera Molecular develops the EnumeraPlex platform, a molecular diagnostics system offering a range of tests with a single workflow and clear result readouts for clinical laboratories.
BiotechHealthtechMedical DevicesAnn Arbor, US
Matthew Cooper(CEO & Co-founder)Dan Kidle(Director)Elaine Heron(Director)Sundaresh Brahmasandra(Director)
Hicuity delivers telemedicine solutions for clinical, staffing, and operational challenges in acute and critical care venues.
Digital HealthHealthtech
PartnerTim Petersen· led
Jumpcode Genomics develops programmable endonuclease enzymes for next-generation sequencing and PCR applications.
BiotechDeep TechSan Diego, US
David Michael Salter(Executive Officer, Director)Eugene Chen(Director)Keith Brown(Executive Officer, Director)Joel Rotroff(Director)
BoardCourt Turner(Director)Joseph Lee(Director)
Molecular diagnostics company offering clinical PCR systems using automation and microfluidics; acquired by QIAGEN in September 2020.
Burke, US
Pezzini Joanna(President)Kevin Hill-Byrne(Vice President)
Pharaoh Neuro develops Neurapheresis™, a medical device platform for precision management of cerebrospinal fluid to restore balance and protect brain health in neurocritical patients, particularly those with subarachnoid hemorrhage from aneurysms or strokes.
Deep TechHealthtechMedical Devices<UNKNOWN>
Amaza Reitmeier(CEO)
BiotechTustin, US
Carl Simpson(Director)David Singer(Director)Krista Mann(Executive Officer)Geoff Brooke(Director)Robert Kuhling(Director)R. King Nelson(Executive Officer, Director)
ViaLase develops a femtosecond laser system for noninvasive glaucoma treatment that creates apertures through the trabecular meshwork in open-angle glaucoma patients.
Deep TechHealthtechMedical DevicesAliso Viejo, US
Tibor Juhasz(Executive Officer, Director)Rick Lewis(Executive Officer)Scott Cooper(Executive Officer)Hadi Srass(Executive Officer)Shawn O'Neil(Executive Officer)
BoardWilliam Link(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Arboretum Ventures invest at?
- Arboretum Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Arboretum Ventures's typical check size?
- Arboretum Ventures typically writes checks of $5M – $15M.
- What sectors does Arboretum Ventures focus on?
- Arboretum Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Arboretum Ventures located?
- Arboretum Ventures is headquartered in Ann Arbor, US.
- Does Arboretum Ventures lead rounds?
- Yes, Arboretum Ventures leads investment rounds.
From the blog
visit blog ↗Arboretum Ventures recently highlighted clinical milestones at its portfolio companies, including full enrollment completion at diabetes device firm Endogenex and first patient enrollment at cardiac rhythm management company AtaCor Medical. AI summary
Media · Podcasts & interviews
featuring the teamJan Garfinkle – Arboretum Ventures (Manager Meetings, EP.09)
Capital Allocators with Ted Seides · Jan Garfinkle
Co-investors · 33
Hatteras Venture Partners is a venture capital firm focused on early-stage life sciences and healthcare companies, backing therapeutics, diagnostics, and businesses aiming to transform healthcare delivery and innovation.
Lightstone Ventures is a life sciences venture firm founded in 2012 that invests in biotech and medtech companies, backing founders translating scientific breakthroughs into therapies and medical technologies.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
F-Prime Capital Partners is a venture capital firm whose team of scientists, engineers, physicians, operators, and investors supports companies in scaling and accelerating growth.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Broadview Ventures is an impact investor focused on accelerating the development of technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.
Beringea is a transatlantic venture capital firm that partners with entrepreneurs to scale high-growth businesses, drawing on funds and networks in both the U.S. and the U.K.
Solas BioVentures is an early-stage venture capital firm based in Chattanooga, Tennessee, investing exclusively in the life science industry across biopharmaceuticals, medical devices, and digital health.
Sequoia Capital is a venture capital firm that partners with founders to build technology companies, with a strong current focus on artificial intelligence.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
.jpeg){kind=logo}
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
▶21 more co-investors
RRE VenturesLiquid VenturesGoodwater CapitalBlockchain CapitalAltaIR CapitalDigital Currency GroupCompany CapitalAmerican Express Ventures (Amex)Accelerator VenturesFuture Perfect Ventures305 VenturesPitbull VenturesGSR VenturesNKM CapitalIGNIA PartnersJungle VenturesHealthQuest CapitalSante VenturesParallax VenturesArcus VenturesPerseverance Capital
Firms observed investing alongside Arboretum Ventures, from public investor directories. Shared companies are the overlap with Arboretum Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Future Positive Capital is an investment firm backing entrepreneurs building companies that address major global challenges and shape more sustainable, preferable futures.